PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes it uniquely placed to support business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest.
PharmaVentures’ services include:
• M&A (divestments, mergers, acquisitions, and strategic transactions)
• Licensing (in and out licensing)
• Fundraising Support
• Strategy (commercialisation, deal strategy, due diligence, market entry)
• Valuation and Positioning (licensing, M&A, and fundraising)
PharmaVentures Capital Ltd is a wholly owned subsidiary of PharmaVentures Ltd. All regulated activities are delivered through PharmaVentures Capital Ltd, which is authorised and regulated by the Financial Conduct Authority (741356).
For more details, visit https://www.pharmaventures.com
Overview
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 14, 2025 | Q1 INTERIM REPORT JULY – SEPT 2025 | Q1 INTERIM REPORT JULY – SEPT 2025 Fri, Nov 14, 2025 09:00 CET Report this content OPENING REMARKS The 2024-2025 financial year was extremely productive for Hamlet BioPharma and this trend continued into the first quarter of the financial y... |
| Nov 4, 2025 | Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations | Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations Tue, Nov 04, 2025 08:30 CET Report this content Inhalation Sciences announced today that the company has engaged the internat... |
| Oct 7, 2024 | Faron announces Capital Markets Day | Faron announces Capital Markets Day Mon, Oct 07, 2024 08:00 CET Report this content Faron Pharmaceuticals Ltd. (“Faron” or “the Company”) Faron announces Capital Markets Day to be held on 22 October 2024 Press release, 7 October 2024 TURKU,... |
| Aug 1, 2024 | GenBio Inc Partners with PharmaVentures to Accelerate Growth in the Biotechnology Industry | GenBio Inc. GenBio Inc, has engaged PharmaVentures, a premier transaction advisory firm with over 30 years of experience in Biotechnology M&A deals Never become so much of an expert that you stop gaining expertise. View life as a contin... |
| Jan 14, 2015 | PharmaVentures becomes latest Partner of One Nucleus | PharmaVentures becomes latest Partner of One Nucleus 14-01-2015 PharmaVentures has become the latest Partner to join forces with One Nucleus. Both PharmaVentures and One Nucleus are committed to playing an active and supportive role in assi... |
Reviews 0
FAQ about PharmaVentures
When was PharmaVentures founded?
PharmaVentures was founded in 1992.
What has the press written about PharmaVentures?
Parsers VC has collected 6 articles mentioning PharmaVentures, among them “Q1 INTERIM REPORT JULY – SEPT 2025” (Nov 14, 2025) and “Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations” (Nov 4, 2025).
Is PharmaVentures still active?
Yes, PharmaVentures is active; its latest activity on Parsers VC dates from Feb 13, 2026.